ESR1 and breast carcinoma: Subsequent treatment of PeRo-Lum1 cells, a luminal mammary cancer cell line, with CAF-conditioned medium resulted in decreased cell sensitivity to tamoxifen through the decrease in ERα expression, suggesting that the interactions between CAFs and cancer cells can alter the molecular subtype of breast cancers and ultimately, endocrine therapy resistance.